Tuesday, 02 January 2024 12:17 GMT

Fennec Pharmaceuticals Inc.


(MENAFN- Baystreet) 10:33 AM EST - Fennec Pharmaceuticals Inc.: Will release its full year and fourth quarter 2025 financial results before the opening of the U.S. financial markets on Tuesday, March 24. Fennec Pharmaceuticals Inc. shares T are trading down $0.01 at $10.72.

MENAFN18032026000212011056ID1110879929



Baystreet.ca

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Search